Patents Assigned to Merck Patents GmbH
  • USE OF CYCLOHEXANOL ETHERS HAVING ANTIMICROBIAL PROPERTIES
    Publication number: 20150118165
    Abstract: The present invention relates to the use of at least one cyclohexanol ether derivative of the formula I as antimicrobial active compound or as anti-acne, antidandruff, deodorant or antiperspirant active compound, to preparations comprising these compounds, and to specific cyclohexanol ether derivatives.
    Type: Application
    Filed: April 5, 2013
    Publication date: April 30, 2015
    Applicant: Merck Patent GmbH
    Inventors: Thomas Rudolph, Sylvia Eisenberg
  • Anthracene derivatives and their use in organic electroluminescent devices
    Patent number: 9017825
    Abstract: The present invention relates to anthracene derivatives which are suitable for use in organic electroluminescent devices, and to organic electroluminescent devices containing these anthracene derivatives.
    Type: Grant
    Filed: December 7, 2006
    Date of Patent: April 28, 2015
    Assignee: Merck Patent GmbH
    Inventors: Holger Heil, Arne Buesing, Philipp Stoessel
  • Indacenodithiophene and indacenodiselenophene polymers and their use as organic semiconductors
    Patent number: 9017577
    Abstract: The invention relates to conjugated polymers comprising indacenodithiophene or indacenoselenophene units or derivatives thereof, to methods of their preparation, to novel monomer units used therein, to the use of the polymers in organic electronic (OE) devices, and to OE devices comprising the polymers.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: April 28, 2015
    Assignee: Merck Patent GmbH
    Inventors: Steven Tierney, Clare Bailey, William Mitchell, Weimin Zhang
  • SMALL MOLECULES AND THEIR USE AS ORGANIC SEMICONDUCTORS
    Publication number: 20150108409
    Abstract: The invention relates to compounds based on benzo[1,2-b:4,5-b?]dithiophene (BDT), methods for their preparation and intermediates used therein, mixtures and formulations containing them, the use of the compounds, mixtures and formulations as semiconductor in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices, and to OE devices comprising these compounds, mixtures or formulations.
    Type: Application
    Filed: May 6, 2013
    Publication date: April 23, 2015
    Applicant: Merck Patent GmbH
    Inventors: Frank Egon Meyer, Nicolas Blouin, Toby Cull, William Mitchell
  • Deuterated Thiazolidinone Analogues as Agonists for Follicle Stimulating Hormone Receptor
    Publication number: 20150111933
    Abstract: The present invention relates to deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor and their use for treating fertility disorders.
    Type: Application
    Filed: January 24, 2013
    Publication date: April 23, 2015
    Applicant: Merck Patent GmbH
    Inventors: Henry Yu, Marianne Donnelly
  • PROCESS FOR PRODUCING THREE-DIMENSIONAL PATTERNS IN LIQUID-CRYSTALLINE COATINGS
    Publication number: 20150110999
    Abstract: The present invention relates to a method for producing three-dimensional macroscopic patterns in liquid-crystalline coatings, patterned layers containing liquid-crystalline materials and produced by said method, and the use thereof in decorative and security products. In the method, the liquid-crystalline coating in a non-solidified state is brought into contact with a printing form for a relief printing method, with the result that depressions which are not deeper than 10 ?m arise in the coating.
    Type: Application
    Filed: May 15, 2013
    Publication date: April 23, 2015
    Applicant: Merck Patent GmbH
    Inventor: Thomas Goetz
  • Nitrogen-containing condensed heterocyclic compounds for OLEDs
    Patent number: 9012599
    Abstract: The present invention relates to compounds of the formula (1), formula (2), formula (3) and formula (4) which are suitable for use in electronic devices, in particular organic electroluminescent devices.
    Type: Grant
    Filed: October 20, 2010
    Date of Patent: April 21, 2015
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Esther Breuning, Dominik Joosten, Christof Pflumm, Amir Hossain Parham
  • COATED TABLETS AND THE PRODUCTION THEREOF
    Publication number: 20150104512
    Abstract: The present invention provides a rapidly disintegrating pharmaceutical formulation in the form of a coated tablet having increased mechanical strength, or hardness. The invention furthermore relates to a process for the production of the coated tablet and to the use of these formulations.
    Type: Application
    Filed: April 2, 2013
    Publication date: April 16, 2015
    Applicant: Merck Patent GmbH
    Inventors: Roberto Ognibene, Sandra Erika Bernhardt, Melanie Mechthild Breidung, Dieter Lubda, Hans-Leonhard Ohrem
  • FORMULATION COMPRISING IONIC ORGANIC COMPOUNDS FOR USE IN ELECTRON TRANSPORT LAYERS
    Publication number: 20150105560
    Abstract: The invention relates to formulations comprising ionic organic compounds for use in electron transport layers or electron collecting layers of organic electronic (OE) devices, more specifically in organic photovoltaic (OPV) devices, to electron transport layers comprising or being made through the use of such formulations, and to OE and OPV devices comprising such formulations or electron transport layers.
    Type: Application
    Filed: April 12, 2013
    Publication date: April 16, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Stephane Berny, Amy Phillips, Priti Tiwana, Toby Cull, Miguel Carrasco-Orozco, Nicolas Blouin
  • Furopyridine derivatives
    Patent number: 9006440
    Abstract: Compounds of the formula I in which R1 and R2 have the meanings indicated in Claim 1, are inhibitors of Syk, and can be employed, inter alia, for the treatment of rheumatoid arthritis and/or systemic lupus.
    Type: Grant
    Filed: July 29, 2011
    Date of Patent: April 14, 2015
    Assignee: Merck Patent GmbH
    Inventors: Lars Burgdorf, Melanie Schultz, Tatjana Ross, Brian Hodous, Justin Potnick, Amanda E. Sutton, Bayard R. Huck
  • Liquid-crystal display
    Patent number: 9005720
    Abstract: Disclosed are liquid-crystal (LC) media for use in LC displays of the PS (polymer stabilized) or PSA (polymer sustained alignment) type which contain a liquid-crystal (LC) mixture that contains one or more compounds of formula I
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: April 14, 2015
    Assignee: Merck Patent GmbH
    Inventors: Achim Goetz, Melanie Klasen-Memmer, Stephan Derow, Sabine Schoen, Peter Best
  • Quinazoline derivatives
    Patent number: 9006255
    Abstract: Compounds of the formula I in which R, X, L2 and A1-A6 have the meanings indicated in Claim 1, are PI3K inhibitors and can be employed, inter alia, for the treatment of autoimmune diseases, inflammation, cardiovascular diseases, neurodegenerative diseases and tumors.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: April 14, 2015
    Assignee: Merck Patent GmbH
    Inventor: Markus Klein
  • Liquid-crystal display
    Patent number: 9005721
    Abstract: Disclosed are liquid-crystal (LC) media for use in LC displays of the PS (polymer stabilized) or PSA (polymer sustained alignment) type which contain a liquid-crystal (LC) mixture that contains one or more compounds of formula I
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: April 14, 2015
    Assignee: Merck Patent GmbH
    Inventors: Achim Goetz, Melanie Klasen-Memmer, Stephan Derow, Sabine Schoen, Peter Best
  • Organic electroluminescence devices containing substituted benzo[C]phenanthrenes
    Patent number: 9006503
    Abstract: The present invention relates to substituted benzo[c]phenanthrene derivatives and to the production and to the use thereof in electronic devices, and to the electronic devices themselves. The present invention relates in particular an electronic device containing 10-benzo[c]phenanthrene derivatives of, e.g., formula (II) substituted with at least one aromatic unit or at least one diarylamino unit.
    Type: Grant
    Filed: January 2, 2014
    Date of Patent: April 14, 2015
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Arne Buesing, Holger Heil, Philipp Stoessel
  • GLUCURONOLACTONE DERIVATIVES AS SELF-TANNING SUBSTANCES
    Publication number: 20150098914
    Abstract: The invention relates to the use of specific glucuronolactone derivatives as self-tanning substances, as tanning enhancers for dihydroxyacetone or for a mixture of self-tanning substances comprising dihydroxyacetone, for modulation of the colour shade achieved in the case of tanning with dihydroxyacetone or by the mixture or preparation comprising dihydroxyacetone, as contrast-reduction agents or for colouring keratin-containing fibres, and to preparations or compositions for colouring keratin-containing fibres comprising these specific glucuronolactone derivatives.
    Type: Application
    Filed: November 10, 2012
    Publication date: April 9, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Christophe Carola, Tatjana Best
  • Selectively etching of a polymer matrix on pet
    Patent number: 8999186
    Abstract: The present invention relates to a method for selectively etching and patterning with high resolution of flexible polymer matrices, which may comprise Ag nano tubes.
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: April 7, 2015
    Assignee: Merck Patent GmbH
    Inventors: Arjan Meijer, Werner Stockum, Ingo Koehler
  • Imidazo[4,5-c]quinolines as DNA-PK inhibitors
    Patent number: 9000153
    Abstract: The invention relates to compounds of the formulae (I) and (II) in which R1, R2, R3, R4, R5, R8, X and m have the meaning indicated in the claims, and/or physiologically acceptable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios. The compounds of the formula (I) can be used for the inhibition of serine/threonine protein kinases and for the sensitization of cancer cells to anticancer agents and/or ionizing radiation. The invention also relates to the use of the compounds of the formula (I) in the prophylaxis, therapy or progress control of cancer, tumors, metastases or angiogenesis disorders, in combination with radiotherapy and/or an anticancer agent. The invention furthermore relates to a process for the preparation of the compounds of the formula (I).
    Type: Grant
    Filed: July 26, 2011
    Date of Patent: April 7, 2015
    Assignee: Merck Patent GmbH
    Inventors: Thomas Fuchss, Werner Mederski, Frank Zenke
  • Materials for organic electroluminescent devices
    Patent number: 8999521
    Abstract: The present invention relates to anthracene derivatives, to the use thereof in organic electroluminescent devices, and to organic electroluminescent devices comprising these compounds.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: April 7, 2015
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Holger Heil, Amir Parham, Horst Vestweber
  • Compounds for a liquid-crystalline medium, and the use thereof for high-frequency components
    Patent number: 8999198
    Abstract: The present invention relates to 1,4-diethynylbenzene derivatives having substituents in the 2,3-position (cf. formula I, Claims), to the use thereof for high-frequency components, to liquid-crystalline media comprising the compounds, and to high-frequency components, in particular antennae, especially for the gigahertz range, comprising these media. The liquid-crystalline media serve, for example, for the phase shifting of microwaves for tuneable ‘phased-array’ antennae.
    Type: Grant
    Filed: September 14, 2011
    Date of Patent: April 7, 2015
    Assignee: Merck Patent GmbH
    Inventors: Volker Reiffenrath, Christian Jasper, Atsutaka Manabe, Elvira Montenegro, Detlef Pauluth
  • Electro-optical light control element, display and medium
    Patent number: 8999461
    Abstract: The present invention relates to an electro-optical light modulation element and to electro-optical displays and display systems, such as television screens and computer monitors, containing elements of this type. The light modulation elements according to the invention contain a mesogenic modulation medium which is in the isotropic phase during operation of the light modulation elements and are particularly distinguished by very short response times in addition to good contrast and low viewing-angle dependence. The mesogenic modulation media used in the electro-optical light modulation elements are likewise a subject-matter of the present invention.
    Type: Grant
    Filed: June 7, 2012
    Date of Patent: April 7, 2015
    Assignee: Merck Patent GmbH
    Inventors: Michael Heckmeier, Achim Gotz